2don MSN
Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and development
It's the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten the time it ...
INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...
Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...
The OpenFold Consortium, a leading nonprofit artificial intelligence (AI) research consortium, today announced a preview release of OpenFold3, an open-source deep learning model that predicts ...
Following three years of internal development, Expedition Medicines is taking flight. The company is supported by a $50 ...
Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and shorten ...
This webinar explores how a high-throughput transcriptomics assay addresses this challenge by enabling genome-wide expression ...
Japan biotech xFOREST Therapeutics is teaming up with a drug discovery solutions provider in a research pact aiming to develop new RNA structure-targeted small molecule therapeutics, including mRNA ...
WuXi AppTec, a global contract research, development, and manufacturing organization (CRDMO), recently hosted its 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback